September 23, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn of the risks for encephalopathy and aseptic meningitis in patients receiving metronidazole ...
Watson has resumed shipments of INFeD (iron dextran injection), an intravenous iron replacement therapy for the treatment of patients with documented iron deficiency anemia in whom oral administration ...
Treatment with intravenous low-molecular-weight iron dextran (LMWID) seems to be an effective alternative for patients with nondialysis chronic kidney disease (ND-CKD) who remain anemic despite ...
Credit: Getty Images. The recall was initiated due to product stability testing results that did not meet specifications for iron content. Allergan has expanded its December 2017 voluntary recall of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results